Johnson & Johnson Archives - DelveInsight

Johnson & Johnson

Leading MedTech Companies 2021| Abbott | Medtronic | J&J | Boston Scientific |
Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation

The global coronavirus has affected almost every industry, and medical devices are no less affected. Even as the first quarter of 2021 has passed, the pandemic hasn’t. No industry has gone unharme...


Kidney Cancer
Notizia

FDA discards depression drug ALKS 5461 of AlkermesThe FDA has rejected approval for ALKS 5461 of Alkermes in major depressive disorder. ALKS 5461 is a fixed-dose combination of buprenorphine a...


vedanta
Prometic bags $50M; Vedanta receives $12M; Humira biosimilar deal

Prometic bags USD 50 Million stock sale option to ease a cash crunch Prometic Life Sciences got into an agreement for selling USD 50 million in stock. This gives Prometic a way to escape its curren...


Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug

Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed t...


Hot flashes
Notizia

FDA approves expanded label for Xarelto of Johnson & JohnsonThe Food and Drug Administration permitted labelling of blood thinner, Xarelto of Johnson & Johnson, as it can decrease the ris...


Johnson & Johnson
Hologic complements Focal; Allogene for IPO; Gamida, Novartis-backed cell therapy startup; Aduro ...

Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 MillionHologic, a global champion of women's health based in Massachusetts, United States, is taking possession...


Default Blog Image
Horizon Discovery declines Abcam’s USD 367 million takeover bid

Horizon Discovery declines Abcam’s USD 367 million takeover bid Horizon Discovery has recently rejected a buyout bid worth USD 367 million from Abcam. Horizon Discovery is an expert in gene editing...


Personalized Medicine
Teva sells generics; Valeant trades; Roche’s Genentech; J&J’s next potential fro...

Teva looks to sell generics in China through joint venture with Guangzhou Pharma As the world’s largest generics maker, Teva still doesn’t have much of a presence in China, even though it is a coun...


Default Blog Image
Emergence of Stem cells and its Market Impact

Big Pharma Guiding the Stem Cells FutureStem cells (SCs) have been an excitement area of medical research since 1800s. In the mid 1800s it was discovered that cells were basically the building b...


Default Blog Image
Oncology Therapeutics Making Big in Coming Years

The industry's 10 biggest-selling cancer drugs generated combined sales of $37.4billion in 2013, with Roche's Rituxan, Avastin and Herceptin franchises extending their lead at the top of this leag...


Editor's Pick
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology ...

Advances in genetics research have sparked a surge in interest in gene therapy in derma...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.